Cargando…
Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833308/ https://www.ncbi.nlm.nih.gov/pubmed/35169571 http://dx.doi.org/10.12890/2022_003042 |
_version_ | 1784648904122302464 |
---|---|
author | Ameri, Maryam Abolmaali, Meysam Alwedaie, Sayed Mohammed Jawad Nabavi, Mohammad Rahimian, Neda Hamidabad, Negin Mahmoodi |
author_facet | Ameri, Maryam Abolmaali, Meysam Alwedaie, Sayed Mohammed Jawad Nabavi, Mohammad Rahimian, Neda Hamidabad, Negin Mahmoodi |
author_sort | Ameri, Maryam |
collection | PubMed |
description | Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, to our knowledge, has no associated major side effects. We describe the case of a 40-year-old female healthcare worker who developed severe persistent eczematous lesions on the second day after she received the first dose of the Sputnik vaccine. The eczematous lesions were refractory to an antihistamine and persisted at the 1 month follow-up. Severe persistent eczematous lesions should be viewed as a potential side effect of vaccination with the Sputnik V vaccine. Moreover, a severe allergic reaction to a COVID-2019 vaccine may indicate the vaccine is ineffective in the recipient. LEARNING POINTS: Vaccination against COVID-19 may be accompanied by rare complications. Eczematous lesions can be a side effect of the Sputnik V vaccine. A severe allergic reaction to a COVID-19 vaccine may result in decreased vaccine effectiveness in the recipient. |
format | Online Article Text |
id | pubmed-8833308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-88333082022-02-14 Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine Ameri, Maryam Abolmaali, Meysam Alwedaie, Sayed Mohammed Jawad Nabavi, Mohammad Rahimian, Neda Hamidabad, Negin Mahmoodi Eur J Case Rep Intern Med Articles Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, to our knowledge, has no associated major side effects. We describe the case of a 40-year-old female healthcare worker who developed severe persistent eczematous lesions on the second day after she received the first dose of the Sputnik vaccine. The eczematous lesions were refractory to an antihistamine and persisted at the 1 month follow-up. Severe persistent eczematous lesions should be viewed as a potential side effect of vaccination with the Sputnik V vaccine. Moreover, a severe allergic reaction to a COVID-2019 vaccine may indicate the vaccine is ineffective in the recipient. LEARNING POINTS: Vaccination against COVID-19 may be accompanied by rare complications. Eczematous lesions can be a side effect of the Sputnik V vaccine. A severe allergic reaction to a COVID-19 vaccine may result in decreased vaccine effectiveness in the recipient. SMC Media Srl 2022-01-12 /pmc/articles/PMC8833308/ /pubmed/35169571 http://dx.doi.org/10.12890/2022_003042 Text en © EFIM 2022 This article is licensed under a Commons Attribution Non-Commercial 4.0 License |
spellingShingle | Articles Ameri, Maryam Abolmaali, Meysam Alwedaie, Sayed Mohammed Jawad Nabavi, Mohammad Rahimian, Neda Hamidabad, Negin Mahmoodi Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title | Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title_full | Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title_fullStr | Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title_full_unstemmed | Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title_short | Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine |
title_sort | severe persistent eczema in a recipient of the gam-covid-vac vaccine |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833308/ https://www.ncbi.nlm.nih.gov/pubmed/35169571 http://dx.doi.org/10.12890/2022_003042 |
work_keys_str_mv | AT amerimaryam severepersistenteczemainarecipientofthegamcovidvacvaccine AT abolmaalimeysam severepersistenteczemainarecipientofthegamcovidvacvaccine AT alwedaiesayedmohammedjawad severepersistenteczemainarecipientofthegamcovidvacvaccine AT nabavimohammad severepersistenteczemainarecipientofthegamcovidvacvaccine AT rahimianneda severepersistenteczemainarecipientofthegamcovidvacvaccine AT hamidabadneginmahmoodi severepersistenteczemainarecipientofthegamcovidvacvaccine |